List of Excipients in API atomoxetine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing atomoxetine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eli Lilly and Company | STRATTERA | atomoxetine hydrochloride | 0002-3227 | DIMETHICONE | |
| Eli Lilly and Company | STRATTERA | atomoxetine hydrochloride | 0002-3227 | GELATIN | |
| Eli Lilly and Company | STRATTERA | atomoxetine hydrochloride | 0002-3227 | SODIUM LAURYL SULFATE | |
| Eli Lilly and Company | STRATTERA | atomoxetine hydrochloride | 0002-3227 | STARCH, CORN | |
| Eli Lilly and Company | STRATTERA | atomoxetine hydrochloride | 0002-3227 | TITANIUM DIOXIDE | |
| TYA Pharmaceuticals | STRATTERA | atomoxetine hydrochloride | 64725-3228 | DIMETHICONE | |
| TYA Pharmaceuticals | STRATTERA | atomoxetine hydrochloride | 64725-3228 | FD&C BLUE NO. 2 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing atomoxetine hydrochloride
Detailed excipient profiles for atomoxetine hydrochloride
Excipient focus: DIMETHICONE
atomoxetine hydrochloride drug variants containing DIMETHICONE
atomoxetine hydrochloride drug variants not containing DIMETHICONE
Excipient focus: FD&C BLUE NO. 2
atomoxetine hydrochloride drug variants containing FD&C BLUE NO. 2
atomoxetine hydrochloride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE RED
atomoxetine hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | atomoxetine hydrochloride | 50090-4243 |
| A-S Medication Solutions | atomoxetine hydrochloride | 50090-4244 |
| >Company | >Ingredient | >NDC |
atomoxetine hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
atomoxetine hydrochloride drug variants containing FERRIC OXIDE YELLOW
atomoxetine hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
atomoxetine hydrochloride drug variants containing FERROSOFERRIC OXIDE
atomoxetine hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
atomoxetine hydrochloride drug variants containing GELATIN
atomoxetine hydrochloride drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
atomoxetine hydrochloride drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | atomoxetine hydrochloride | 0781-2260 |
| >Company | >Ingredient | >NDC |
atomoxetine hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
atomoxetine hydrochloride drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | atomoxetine hydrochloride | 0781-2260 |
| >Company | >Ingredient | >NDC |
atomoxetine hydrochloride drug variants not containing SHELLAC
Excipient focus: SODIUM LAURYL SULFATE
atomoxetine hydrochloride drug variants containing SODIUM LAURYL SULFATE
atomoxetine hydrochloride drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
atomoxetine hydrochloride drug variants containing STARCH, CORN
atomoxetine hydrochloride drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
atomoxetine hydrochloride drug variants containing TITANIUM DIOXIDE
atomoxetine hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
